TORUTAMIG
UNII N89BPG3SVA

Substance Identification & Data

This profile provides standardized clinical and technical data for Torutamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N89BPG3SVA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3075939-10-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

N89BPG3SVA

CAS Registry Number

3075939-10-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TORUTAMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13997

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Torutamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TORUTAMIG

Common Names & Synonyms

IMMUNOGLOBULIN (H-GAMMA1_V-LAMBDA-C-KAPPA)_(V-KAPPA-C-GAMMA1_VH-C-KAPPA), ANTI-(HOMO SAPIENS TNFRSF17 (TUMOR NECROSIS FACTOR (TNF) RECEPTOR SUPERFAMILY MEMBER 17, B CELL MATURATION ANTIGEN, BCMA, TNFRSF13A, CD269)) AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)), CHIMERIC, HOMO SAPIENS MONOCLONAL ANTIBODY, BISPECIFIC, BIVALENT (TORUTAMIG)

IMMUNOGLOBULIN G1, BISPECIFIC, (238-ALANINE,239-ALANINE,256-TYROSINE,258-THREONINE,260-GLUTAMIC ACID,353-CYSTEINE,370-SERINE,372-ALANINE,411-VALINE), ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17) (HUMAN-LAMA GLAMA MONOCLONAL BCD-248 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL BCD-248 .KAPPA.-CHAIN, (230->217'),(233->220'),(353->345')-TRIS(DISULFIDE) WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL BCD-248 LIGHT CHAIN VARIABLE REGION) FUSION PROTEIN WITH PEPTIDE LINKER (TVSS) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (117'-ALANINE,118'-ALANINE,135'-TYROSINE,137'-THREONINE,139'-GLUTAMIC ACID,237'-CYSTEINE,249'-TRYPTOPHAN) (HUMAN .GAMMA.1-CHAIN CONSTANT REGION) DISULFIDE WITH IMMUNOGLOBULIN (HUMAN MONOCLONAL BCD-248 HEAVY CHAIN VARIABLE REGION) FUSION PROTEIN WITH PEPTIDE LINKER (EIK) FUSION PROTEIN WITH HUMAN MONOCLONAL BCD-248 .KAPPA.-CHAIN CONSTANT REGION

TORUTAMIG [INN]

External Clinical & Regulatory Resources

Previous UNIIN89789EA9P

Next UNIIN89ENH3CTU